168 related articles for article (PubMed ID: 37932182)
1. An integrated model combined intra- and peritumoral regions for predicting chemoradiation response of non small cell lung cancers based on radiomics and deep learning.
Ma Y; Li Q
Cancer Radiother; 2023 Dec; 27(8):705-711. PubMed ID: 37932182
[TBL] [Abstract][Full Text] [Related]
2. Predicting N2 lymph node metastasis in presurgical stage I-II non-small cell lung cancer using multiview radiomics and deep learning method.
Zhang H; Liao M; Guo Q; Chen J; Wang S; Liu S; Xiao F
Med Phys; 2023 Apr; 50(4):2049-2060. PubMed ID: 36563341
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral and peritumoral CT-based radiomics strategy reveals distinct subtypes of non-small-cell lung cancer.
Tang X; Huang H; Du P; Wang L; Yin H; Xu X
J Cancer Res Clin Oncol; 2022 Sep; 148(9):2247-2260. PubMed ID: 35430688
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Intratumoral and Peritumoral Computed Tomography Radiomics for Predicting Pathological Complete Response to Neoadjuvant Chemoradiation in Patients With Esophageal Squamous Cell Carcinoma.
Hu Y; Xie C; Yang H; Ho JWK; Wen J; Han L; Chiu KWH; Fu J; Vardhanabhuti V
JAMA Netw Open; 2020 Sep; 3(9):e2015927. PubMed ID: 32910196
[TBL] [Abstract][Full Text] [Related]
5. Predicting programmed death-ligand 1 expression level in non-small cell lung cancer using a combination of peritumoral and intratumoral radiomic features on computed tomography.
Shiinoki T; Fujimoto K; Kawazoe Y; Yuasa Y; Kajima M; Manabe Y; Ono T; Hirano T; Matsunaga K; Tanaka H
Biomed Phys Eng Express; 2022 Feb; 8(2):. PubMed ID: 35051908
[TBL] [Abstract][Full Text] [Related]
6. Enhancing brain metastasis prediction in non-small cell lung cancer: a deep learning-based segmentation and CT radiomics-based ensemble learning model.
Gong J; Wang T; Wang Z; Chu X; Hu T; Li M; Peng W; Feng F; Tong T; Gu Y
Cancer Imaging; 2024 Jan; 24(1):1. PubMed ID: 38167564
[TBL] [Abstract][Full Text] [Related]
7. Deep-learning-based radiomics of intratumoral and peritumoral MRI images to predict the pathological features of adjuvant radiotherapy in early-stage cervical squamous cell carcinoma.
Zhang XF; Wu HY; Liang XW; Chen JL; Li J; Zhang S; Liu Z
BMC Womens Health; 2024 Mar; 24(1):182. PubMed ID: 38504245
[TBL] [Abstract][Full Text] [Related]
8. Predicting chemotherapy response in non-small-cell lung cancer
Chang R; Qi S; Zuo Y; Yue Y; Zhang X; Guan Y; Qian W
Front Oncol; 2022; 12():915835. PubMed ID: 36003781
[TBL] [Abstract][Full Text] [Related]
9. Role of intratumoral and peritumoral CT radiomics for the prediction of EGFR gene mutation in primary lung cancer.
Yamazaki M; Yagi T; Tominaga M; Minato K; Ishikawa H
Br J Radiol; 2022 Dec; 95(1140):20220374. PubMed ID: 36115683
[TBL] [Abstract][Full Text] [Related]
10. Ct-based subregional radiomics using hand-crafted and deep learning features for prediction of therapeutic response to anti-PD1 therapy in NSCLC.
Hu Y; Jiang T; Wang H; Song J; Yang Z; Wang Y; Su J; Jin M; Chang S; Deng K; Jiang W
Phys Med; 2024 Jan; 117():103200. PubMed ID: 38160516
[TBL] [Abstract][Full Text] [Related]
11. Radiomics model based on intratumoral and peritumoral features for predicting major pathological response in non-small cell lung cancer receiving neoadjuvant immunochemotherapy.
Huang D; Lin C; Jiang Y; Xin E; Xu F; Gan Y; Xu R; Wang F; Zhang H; Lou K; Shi L; Hu H
Front Oncol; 2024; 14():1348678. PubMed ID: 38585004
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive radiomic biomarkers for predicting pseudoprogression and hyperprogression in patients with non-small cell lung cancer treated with immune checkpoint inhibition.
Li Y; Wang P; Xu J; Shi X; Yin T; Teng F
Oncoimmunology; 2024; 13(1):2312628. PubMed ID: 38343749
[TBL] [Abstract][Full Text] [Related]
13. MRI-based multiregional radiomics for preoperative prediction of tumor deposit and prognosis in resectable rectal cancer: a bicenter study.
Li H; Chen XL; Liu H; Liu YS; Li ZL; Pang MH; Pu H
Eur Radiol; 2023 Nov; 33(11):7561-7572. PubMed ID: 37160427
[TBL] [Abstract][Full Text] [Related]
14. CT radiomics-based model for predicting TMB and immunotherapy response in non-small cell lung cancer.
Wang J; Wang J; Huang X; Zhou Y; Qi J; Sun X; Nie J; Hu Z; Wang S; Hong B; Wang H
BMC Med Imaging; 2024 Feb; 24(1):45. PubMed ID: 38360550
[TBL] [Abstract][Full Text] [Related]
15. Radiomics study for predicting the expression of PD-L1 in non-small cell lung cancer based on CT images and clinicopathologic features.
Sun Z; Hu S; Ge Y; Wang J; Duan S; Song J; Hu C; Li Y
J Xray Sci Technol; 2020; 28(3):449-459. PubMed ID: 32176676
[TBL] [Abstract][Full Text] [Related]
16. Intratumoral and peritumoral radiomics for preoperatively predicting the axillary non-sentinel lymph node metastasis in breast cancer on the basis of contrast-enhanced mammography: a multicenter study.
Lin F; Li Q; Wang Z; Shi Y; Ma H; Zhang H; Zhang K; Yang P; Zhang R; Duan S; Gu Y; Mao N; Xie H
Br J Radiol; 2023 Mar; 96(1143):20220068. PubMed ID: 36542866
[TBL] [Abstract][Full Text] [Related]
17. The CT-based intratumoral and peritumoral machine learning radiomics analysis in predicting lymph node metastasis in rectal carcinoma.
Yuan H; Xu X; Tu S; Chen B; Wei Y; Ma Y
BMC Gastroenterol; 2022 Nov; 22(1):463. PubMed ID: 36384504
[TBL] [Abstract][Full Text] [Related]
18. Deep learning-radiomics integrated noninvasive detection of epidermal growth factor receptor mutations in non-small cell lung cancer patients.
Kim S; Lim JH; Kim CH; Roh J; You S; Choi JS; Lim JH; Kim L; Chang JW; Park D; Lee MW; Kim S; Heo J
Sci Rep; 2024 Jan; 14(1):922. PubMed ID: 38195717
[TBL] [Abstract][Full Text] [Related]
19. Gd-EOB-DTPA-enhanced MRI radiomics to predict vessels encapsulating tumor clusters (VETC) and patient prognosis in hepatocellular carcinoma.
Yu Y; Fan Y; Wang X; Zhu M; Hu M; Shi C; Hu C
Eur Radiol; 2022 Feb; 32(2):959-970. PubMed ID: 34480625
[TBL] [Abstract][Full Text] [Related]
20. Can quantitative peritumoral CT radiomics features predict the prognosis of patients with non-small cell lung cancer? A systematic review.
Wu L; Lou X; Kong N; Xu M; Gao C
Eur Radiol; 2023 Mar; 33(3):2105-2117. PubMed ID: 36307554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
